Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

What Makes EvoLV a Leader in Life Sciences Consulting?

Aug 17, 2025

Innovative Strategies in Life Sciences Consulting

EvoLV has consistently been recognized as a leader in life sciences consulting, thanks to its innovative strategies and commitment to excellence. With a team of seasoned experts, EvoLV brings cutting-edge solutions to its clients, helping them navigate the complex landscape of life sciences. This commitment to innovation is what sets EvoLV apart from its competitors.

The company employs a holistic approach to consulting, ensuring that every aspect of a client's needs is addressed. From research and development to commercialization, EvoLV provides comprehensive support that helps clients achieve their strategic goals. This attention to detail and dedication to client success is a hallmark of their consulting practice.

life sciences team

Expertise Across Multiple Disciplines

One of the key strengths of EvoLV is its multidisciplinary team of experts. The company boasts a diverse roster of professionals with extensive backgrounds in various fields, including biology, chemistry, pharmacology, and regulatory affairs. This diversity allows EvoLV to provide well-rounded insights and solutions tailored to the unique challenges faced by each client.

By leveraging this wide range of expertise, EvoLV can address complex problems from multiple angles, ensuring that no stone is left unturned. This comprehensive approach not only enhances the effectiveness of their solutions but also fosters innovation and creativity within the team.

consulting discussion

Commitment to Client Success

EvoLV’s dedication to client success is evident in their personalized service offerings. The company takes the time to understand the specific needs and objectives of each client, crafting customized strategies that deliver tangible results. This client-centric approach ensures that every project is aligned with the client's vision and goals.

The firm also places a strong emphasis on building long-term relationships with clients. By fostering open communication and collaboration, EvoLV ensures that they remain a trusted partner throughout the entire consulting process. This ongoing support is instrumental in helping clients adapt to changing market conditions and emerging challenges.

client meeting

Embracing Technology and Innovation

In the rapidly evolving field of life sciences, staying ahead of technological advancements is crucial. EvoLV embraces this challenge by integrating the latest technologies into their consulting practices. From data analytics to digital transformation, EvoLV leverages cutting-edge tools to enhance their service offerings and deliver superior results.

This focus on technology not only improves efficiency but also provides clients with actionable insights that drive strategic decision-making. By staying at the forefront of technological innovation, EvoLV ensures that their clients are well-equipped to compete in a fast-paced industry.

technology progress

A Proven Track Record of Success

EvoLV’s reputation as a leader in life sciences consulting is backed by a proven track record of success. The firm has helped numerous clients achieve significant milestones in their respective fields, from successful product launches to regulatory approvals. This track record is a testament to the efficacy of EvoLV's methodologies and their unwavering commitment to excellence.

As a trusted partner, EvoLV continues to set new standards in life sciences consulting, consistently delivering results that exceed client expectations. This ongoing success cements their position as an industry leader and a go-to resource for organizations seeking expert guidance in life sciences.

success story